Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 3 EP applications Mark David Ness has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 4, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14772420

THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 9/51, A61K 31/00, A61K 47/12
Agent:
Multiple attorneys, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
The patent has been granted
EP15725113

PROCESSES FOR THE PREPARATION OF AZD5363 AND NOVEL INTERMEDIATE USED THEREIN

IPC classification:
C07D 487/04, C07D 498/10
Applicant:
AstraZeneca AB
Agent:
Mark David Ness, AstraZeneca AB
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15711272

METHOD OF TREATING SKIN CONDITIONS

IPC classification:
A61K 31/4995, A61P 17/08
Applicant:
AstraZeneca AB
Agent:
HGF Limited
Agent:
Mark David Ness, AstraZeneca AB
Agent:
AstraZeneca PLC
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature